The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Akorn Gets Warning Letter from FDA
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
pharmamanufacturing
April 2, 2007
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
About the Author
pharmamanufacturing
pharmamanufacturing
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
AI usage in pharma supply chain is moving from pilots to practical deployment: report
Sponsored
Life Sciences Manufacturing Software Buyers Guide
Sponsored
AI Compliance in Life Sciences: 5 Essentials
Trending
Turning molecule making into a digital workflow
India’s CRDMOs poised for growth with passage of BIOSECURE Act in the offing
Reshoring, tariffs dominate 2025’s pharma manufacturing news
Sponsored Picks
Sponsored
7 Steps to Simplify CAPA
Sponsored
Webinar: 2026 Life Sciences Industry Trends: Connecting Quality, Manufacturing, and Asset Management
Sponsored
Accelerating Pharma Digital Transformation: Live Webinar with ISPE
Load More Content